Renub Research

Biopsy Testing Market & Volume Analysis to 2020 - United States

Press Release   •   Jan 20, 2016 03:56 EST

United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.

Renub Research report titled “United States – Biopsy Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.

The United States Biopsy Market has been analyzed from two view points

United States Biopy Test Market & Forecast (2008 – 2020)

United States Biopy Test Volume & Forecast (2008 – 2020)

The Top 5 Cancer Segments covered are:

1.Breast Cancer

2.Prostate Cancer

3.Liver Cancer

4.Lung Cancer

5.Thyroid Cancer

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Click here to view the report details: http://www.renub.com/united-states-biopsy-testing-market-and-volume-analysis-to-2020-511-p.php

For more information visit: http://www.renub.com/

Contact Us

Rajat Gupta

Sr. Manager

Sales & Marketing Div

Renub Research

Email: rajat.gupta@renub.com

Phone: Phone: +1-678-302-0700 (USA), +91-120-421-9822, +91-120-424-9780 (India)

Web: http://www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.